Clinical Trials Browser

Phase 1 × Withdrawn × regorafenib × Clear all

NCT02439723 2021-06-23

Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients

Phase 1 Withdrawn

Metastatic Solid Malignancies